A new vaccine is set to undergo testing based on the use of non-pathogenic viruses with anti-cancer activity, which will be administered to patients.Russia will begin Phase 1 clinical trials ...
Australian Researchers Discover that mRNA Vaccines Entering the Bloodstream May Cause Side Effects Such as Headaches and Fever.A study led by researchers from RMIT University and the Peter Doherty Institute ...
mRNA Vaccine for Malignant Tumors Expected to Launch in 2025 Following Approval from US and European Regulators.Recently, the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) ...
